logo
  • 首页
  • 学术期刊
  • 论文检测
  • AIGC检测
  • 热点
  • 更多
    • 数据

Carboplatin/Pembrolizumab/PemetrexedLack of efficacy and pleural tuberculosis

被引:0
|
作者:
机构:
来源:
Reactions Weekly | 2024年 / 2006卷 / 1期
关键词:
D O I:
10.1007/s40278-024-58065-9
中图分类号:
学科分类号:
摘要:
引用
收藏
页码:170 / 170
相关论文
共 50 条
  • [21] Carboplatin/pemetrexedLack of efficacy: case report
    Reactions Weekly, 2023, 1948 (1) : 120 - 120
  • [22] Carboplatin/pemetrexedLack of efficacy: case report
    Reactions Weekly, 2024, 2025 (1) : 115 - 115
  • [23] Carboplatin/pemetrexedLack of efficacy: case report
    Reactions Weekly, 2023, 1942 (1) : 80 - 80
  • [24] Carboplatin/pemetrexedLack of efficacy: case report
    Reactions Weekly, 2021, 1840 (1) : 109 - 109
  • [25] Carboplatin/durvalumab/pemetrexedLack of efficacy: case report
    Reactions Weekly, 2023, 1959 (1) : 173 - 173
  • [26] Carboplatin/pemetrexedLack of efficacy: 2 case reports
    Reactions Weekly, 2022, 1913 (1) : 133 - 133
  • [27] Carboplatin/erlotinib/pemetrexedLack of efficacy: case report
    Reactions Weekly, 2022, 1907 (1) : 126 - 126
  • [28] Cisplatin/pembrolizumab/pemetrexedLack of efficacy: case report
    Reactions Weekly, 2023, 1964 (1) : 137 - 137
  • [29] Carboplatin/docetaxel/pemetrexedLack of efficacy: case report
    Reactions Weekly, 2024, 2030 (1) : 116 - 116
  • [30] Bevacizumab/carboplatin/pemetrexedLack of efficacy: case report
    Reactions Weekly, 2022, 1907 (1) : 110 - 110
← 12345 →